C. Semsarian

Cardiology and Cardiovascular Medicine · 2007–2020

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 111 citations into it; #805 of 906 by trust here, #128 by citations

Whom C. Semsarian trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. B. Maron
2. M. Maron

Who trusts C. Semsarian overall

1. B. Maron

Papers from C. Semsarian's perspective

Ordered by how strongly the researchers C. Semsarian trusts endorse each paper. Same corpus, a different order for every researcher.

1. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (Circulation)
2. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). (European Heart Journal)
3. Guidelines for investigating causality of sequence variants in human disease
4. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy (Circulation)
5. Nonparametric Estimation from Incomplete Observations
6. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.
7. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
8. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. (New England Journal of Medicine)
9. Hypertrophic cardiomyopathy: a systematic review.
10. Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy (New England Journal of Medicine)

Their papers

• 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2020) — 818 citations
• Adaptation and Validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: Recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel (2018) — 334 citations
• A Prospective Study of Sudden Cardiac Death among Children and Young Adults. (2016) — 739 citations
• New perspectives on the prevalence of hypertrophic cardiomyopathy. (2015) — 1,241 citations
• Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. (2014) — 632 citations
• Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy. (2011) — 101 citations
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). (2011) — 872 citations
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). (2011) — 1,312 citations
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. (2007) — 715 citations